{"name":"BioCorRx Pharmaceuticals Inc","slug":"biocorrx-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"BioCorRx Pharmaceuticals Inc is a biotechnology company focused on developing innovative treatments for addiction and other chronic diseases. The company's lead product, BICX104, an implantable naltrexone pellet, is currently in Phase 1 clinical trials, while another program involving the use of lofexidine in standard of care is in Phase 2.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOZ3RObjVoVkVZSGJmOXlRMHo4aHkwdzhTeXR2TkJad1Y4UFZMY0RIYkNCRFRueWtYbnR2VGRpS2NDeEFrdjRuSExtZUJ3a0pKT1Mtck4ySlBBV2pXY0ZmaXo0dndjdFFQcFVSUks1a2E2NFdYTDFUcjd0dkFia2g0TWtWS1plSzN5dVI1N0JVcEJxQ1JTc1pINHdDcnJ6ekQ1SDF4Rjd5elNjN09yYmZ3UUdR?oc=5","date":"2026-04-02","type":"deal","source":"TipRanks","summary":"BioCorRx Reorganizes Subsidiary Through Equity Exchange Deal - TipRanks","headline":"BioCorRx Reorganizes Subsidiary Through Equity Exchange Deal","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AJBVV95cUxOcWdtWlF4SU1sUzlOOXlKU2g1Yjh6YlYzS0ZYSlFuZHhubDhYd19Cc0V2NUFEcXlSeURLbkVzSHBSaWFEWFRKVnJKbFpkby1pa3VGR3k3UHlnOF9Gd1NlTk55WmlsQ0FMLTU4ZWNkUmF0azVRVGJYTnlaQ2g4bFFVeVI3djFZWXBNZ1BMT0MwTlVfdUZMeEZ6SW1pak1udWFHUldYLU9pemh2b0YxSGttRnBoZnd6SU9TOVl1cjAwcHRSaDRxSEQzaVBmVnFNdDFQMzhFRVNrOU9ONEdLTHB6ZDE3aGtqNTNRdF8tYXJYNWQ4cnRCVTR2cUtfa0IxVDZWa3FRa0h0UFUxMVJ5bFF0aVYybjNzb29nTWJISVEyU1g3aVhzSjRQNlV1cjJkV2FKRmd3TVVmR24wWjRrWUxOLXh6X1NqUmVMUUNIZFFxdEJTZ1ZoZmN6TFRVaWN3U0huc2tNdQ?oc=5","date":"2024-03-13","type":"deal","source":"Business Wire","summary":"Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and Milestone Payments for Deals Signed Since 2020 - ResearchAndMarkets.com - Busin","headline":"Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNTFlBbUNzcURPVUxxTmtSUS1JSC1wSHppWG5rMXpDMUl1RmVnRmV2SVhKdG5ock5XVGh1S0dxWWc2VjBNWXVqY0RLdHNVUldvUnlraGt5cGlnaFdXU2RYNmFwNmJ5aXpkNWZUTmFYV3M5VFJMb0w2R3BJcmNVU29od1FNZ2JJQnVtcEN0ZUlkclQ1RzZweHdKWmx6T1lEaENkd2NpY1dZZVZvU2c?oc=5","date":"2021-10-20","type":"pipeline","source":"Orange County Register","summary":"Addiction: Anaheim firm to test implant that blunts a drug user’s high - Orange County Register","headline":"Addiction: Anaheim firm to test implant that blunts a drug user’s high","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQdVVzUWZlMEJqaHdWV0lzUnRabjZ3QUU4Q0EzWTVHcDJyOWRnMGtmWnVCenY3cFdjU2VsOGZKMlI4Rms2bzBkNXozb0FydndCdUJyM0s0aDNwdzhKUXo0V1NZMFVPZjJrRGhVWkd4MXF4VWlabUZXWmtENjRfMS0yMGUyNzFnMGFvNGVTOG1QQ25aa094LVd1ajFhNHVGUEczSnc4TmRCSHk3RWxzOG50SDNiTjRRTHc?oc=5","date":"2021-08-27","type":"pipeline","source":"ABC15 Arizona","summary":"Medical breakthrough on the horizon for those fighting substance abuse disorders - ABC15 Arizona","headline":"Medical breakthrough on the horizon for those fighting substance abuse disorders - ABC15 Arizona","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxORDQxUFZ0SmRiQmdkRzZ6MjdYcDM2dWo1Tkw2X3JUT243bFpvemVMQWRpcEhkaElReUd5b3A5RVdOSWk0T2Jzazc5Ni1OSW8zUmN3aHJWSGNSdEl0X1BvV2JhSjdzQXVKeW05UnZlWkJGVUo4V1FZenhiSmFzZHowTGhWdzdBT1lKUHB3ZGFGUFhrVmdBNnJVUjlwd05JS2xnWklvem9tSUtDM3lZamFZeGJBa3pFZ3hMLW5TUjFqdFNPNzllaWNwZGJiT2NsWmRQemQ3UjlDVDBjdmVVc2dPSDJGTDZPdw?oc=5","date":"2019-12-01","type":"regulatory","source":"Public Citizen","summary":"Outrage of the Month: Company Tested Unapproved Implanted Drug on Louisiana Prisoner in Apparent Illegal Clinical Trial - Public Citizen","headline":"Outrage of the Month: Company Tested Unapproved Implanted Drug on Louisiana Prisoner in Apparent Illegal Clinical Trial","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOalhVMmxNQ2ZzWjNlRFlOOUl4SzRQMjN0b3hTbUxBVHBkY1BaLTNZLUpLWkhYejZINl91UEQwd2RhaFpmUHlCWUdiRFFIWUtBbF9oY2cyR3ZsQzd2QVR4bVhpWTFaX3g0ckt1V0o3cmJ1bTA1MnVtbzZuaXRuMjh2dTE0bS1wWVp3SUhYNGVtaGV2ZzVGdkIzMzZsN2s?oc=5","date":"2019-11-21","type":"regulatory","source":"Fierce Biotech","summary":"FDA urged to probe naltrexone implant tests on prison inmates - Fierce Biotech","headline":"FDA urged to probe naltrexone implant tests on prison inmates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNV0tMWFdKM0tFLVgtRHhVQldteHJhX2FfRFkwemlVVjRrUEtoMndxVzZTYnFwLXN1WG9YUXozb2htMmZWYmE0NUdxUENZbThuR0o1UTlmczc1b2JpYXBGQnQxTmlBR3RzTnBXR1dUdFFsaVA1aUtXQTZCblQ4ZGtyYnhYSURXY2JsUElUNUlJRjdOSUlPb3c?oc=5","date":"2019-10-31","type":"pipeline","source":"newrepublic.com","summary":"Did a Drug Company Illegally Experiment on a Louisiana Prisoner? - newrepublic.com","headline":"Did a Drug Company Illegally Experiment on a Louisiana Prisoner?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}